• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Investments

Benelux: New investments slow down while large exits abound

Benelux funds are experiencing one way traffic
  • Alice Murray
  • Alice Murray
  • 21 March 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Fresh deal activity in the Benelux region has been lacklustre so far for 2016, both in terms of volume and value – but a handful of sizable trade sales could mean Q1 is the highest performing quarter in terms of combined exit value in recent months. Alice Murray reports

The Benelux region appears to be slowing down when it comes to new deals. For the first quarter of 2015, unquote" data recorded 38 deals valued at €2.7bn. Since then, the volume of deals witnessed in the region has steadily decreased, recording 36 in Q2, 30 in Q3, 27 in Q4, and 23 with two weeks left in the first quarter of 2016 at the time of writing.

However, total deal value has been more sporadic, with combined totals coming in at €2.7bn for Q1 2015, rising to €4.5bn for Q2, and even further to €6.5bn for Q3, then falling sharply to €3bn in Q4 2015. And for the relatively fewer deals done at the beginning of 2016, aggregate deal value is even more subdued at just €427m.

Given the slump in new deal activity, it is interesting to see diverging developments on the exit side. For 2016 so far, there have been just five exits in the Benelux region, an even more lacklustre result when compared with new investments. However, in terms of combined value, the picture is very different.

This year has seen a handful of notable exits, including Gimv's sale of Punch Powertrain to Chinese trade buyer Yinyi in a deal worth €1bn. Another stand-out deal was Towerbook's sale of Van Geloven; after investing in the business less than a year ago, the private equity house sold its majority stake in the Dutch frozen food producer to Canadian trade buyer McCain Foods. While the value of this deal remains strictly confidential, we can assume it was somewhere above the €300m level, as Towerbrook used a €150m debt package to finance its acquisition the previous year, and revenues for 2015 came in at €197m.

Also included in this year's exit tracker was 3i's refinancing of Action, which totalled €1.2bn. Furthermore, Gimv scored a further divestment through the sale of VCST to trade buyer BMT Group. The value was undisclosed; however, with turnover of €169m reported in 2015 we can safely assume the sale is at least somewhere in the €200m region.

All together, these exits amount to an estimated total of €2.7bn. But crucially, the quarter is not over yet, and looking at rumoured transactions, there seems to be a very strong likelihood of more exit activity.

Outbound traffic
The newswires have been closely following CVC's plans to sell Dutch HR software and services provider Raet, with the GP bringing in Rothschild to run a process. The sale of Raet is likely to be valued at between €376-564m, or 8-12x its 2014 earnings of €47m on revenues of €147.9m. If this is the case, the divestment is unlikely to result in a home run for CVC given the private equity house paid around €400m for Raet in 2011 (sellers Advent and Taros Capital were reported to have been seeking around 8x EBITDA for the business).

Another exit could come in the form of Holland Venture Partners' sale of Opdidakt, which is likely to be acquired by Karmijn Kapital.

If these deals take place before the end of the quarter, or within the next two weeks, then despite the dramatic fall in deal volume for the first three months of the year (potentially rising to just seven), the period could be one of the highest performers in value terms compared with previous quarters.

In Q1 2015, the region's combined exit value was €2.5bn via 19 deals; in Q2 it was €2.6bn through 18 deals; in Q3 it was €3.2bn, and in Q4 exit total hit €4.9bn – although it must be noted that almost half of the Q4 total can be attributed to the sale of Acerta Pharma for €2.4bn.

But even with just seven potential deals for the first three months of 2016, Benelux's combined exit value for Q1 could hit somewhere around the €3.06bn mark; an impressive sum given the scarcity of divestments.

The striking combined total is testament to local GPs' ability to attract trade buyers, which typically have deeper pockets than other private equity bidders. Indeed, of the five divestments seen so far this year, four have been trade sales.

Further reading

  • Exits
Gimv et al. in final exit of Punch Powertrain
  • 11 Mar 2016
  • Benelux
Towerbrook in swift partial exit from Van Geloven
  • 04 Mar 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Investments
  • Benelux
  • Benelux
  • Top story
  • Gimv
  • Towerbrook Capital Partners
  • 3i
  • CVC Capital Partners

More on Investments

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Reima Linnanvirta of Trind VC
Trind VC plans up to five early-stage investments in next six months

VC has deployed around 10% of its second, EUR 55m fund and plans to invest in up to 40 startups

  • Venture
  • 31 August 2023
Guillaume Fournier of Credo Ventures
Credo Ventures sees activity uptick, plans further deals in 2023 with EUR 75m fourth fund

Czech VC firm's latest vehicle is around 50% deployed and expects to make 25-30 deals in total

  • Venture
  • 23 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013